Prevention and Attenuation of COVID-19 by BNT162b2 and mRNA-1273 Vaccines
Mark G. Thompson, Jefferey L. Burgess, Allison L. Naleway, Harmony Tyner, Sarang K. Yoon, Jennifer Meece, Lauren E.W. Olsho, Alberto J. Caban-Martinez, Ashley L. Fowlkes, Karen Lutrick, Holly C. Groom, Kayan Dunnigan, Marilyn J Odean, Kurt Hegmann, Elisha Stefanski, Laura J. Edwards, Natasha Schaefer-Solle, Lauren Grant, Katherine Ellingson, Jennifer L. Kuntz, Tnelda Zunie, Matthew S. Thiese, Lynn Ivacic, Meredith G. Wesley, Julie Mayo Lamberte, Xiaoxiao Sun, Michael E. Smith, Andrew L. Phillips, Kimberly D. Groover, Young M. Yoo, Joe K. Gerald, Rachel T. Brown, Meghan K. Herring, Gregory Joseph, Shawn Beitel, Tyler C. Morrill, Josephine Mak, Patrick Rivers, Brandon P. Poe, Brian Lynch, Ying Tao Zhou, Jing Zhang, Anna Kelleher, Yan Li, Monica Dickerson, Erika Hanson, Kyley Guenther, Suxiang Tong, Allen Bateman, Erik Reisdorf, John Barnes, Eduardo Azziz-Baumgartner, Danielle R. Hunt, Melissa L. Arvay, Preeta Kutty, Alicia M. Fry, Manjusha Gaglani
medRxiv 2021.06.01.21257987; doi: https://doi.org/10.1101/2021.06.01.21257987